Related Experiment Video
Updated: Feb 23, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Canadian school-based HPV vaccine programs and policy considerations.
Gilla K Shapiro1, Juliet Guichon2, Margaret Kelaher3
1Department of Psychology, McGill University, Montreal, Quebec, Canada; Centre for Health Policy, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
Canadian school-based human papillomavirus (HPV) vaccination programs now include males in six jurisdictions, with uptake varying by sex. Standardizing data collection and considering a national registry are key for future HPV vaccine policy.
Area of Science:
- Public Health
- Immunization Programs
- Vaccinology
Background:
- The National Advisory Committee on Immunization in Canada recommends human papillomavirus (HPV) vaccination for individuals aged 9-26.
- Publicly funded, school-based programs are the primary method for HPV vaccine administration across Canadian provinces and territories.
- This study examines the administration and uptake of HPV vaccination within these school-based programs.
Purpose of the Study:
- To provide an overview of Canadian provincial and territorial school-based HPV vaccination program administration.
- To report on current HPV vaccination rates in Canada.
- To identify policy considerations for future HPV vaccination strategies.
Main Methods:
- A comprehensive search of academic and grey literature was conducted.
- Administrators of provincial and territorial vaccination programs were contacted for data.
- Information on HPV vaccine program administration and vaccination rates was compiled for all 13 Canadian jurisdictions.
Main Results:
- As of October 2016, all 13 Canadian jurisdictions vaccinate females, with six including males in school-based programs.
- Eleven jurisdictions utilize a two-dose HPV vaccination schedule.
- Reported female HPV vaccination uptake ranged from 46.7% to 93.9%, while male uptake (where data was available) ranged from 75.0% to 87.4%.
Conclusions:
- Future research should inform decisions on adopting the nonavalent vaccine and optimizing vaccination schedules (one vs. two doses).
- Improving HPV vaccination uptake and completion rates is a critical public health goal.
- Standardizing data collection methodologies and establishing a national HPV vaccination registry are identified as high priorities.
More Related Videos
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Vaccinations
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Preventive Healthcare Services
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...

